http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180024593-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7b72691b61448140b9a080282c2ccf0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a74935159a0a871dd85e00c138f7fe6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac07412a3fcd0990ac60cc7a574a768c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_976b0f3d5f844588968623ffcd218ef4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29df2237ba01ba9f07c31a72c4216cea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec69ab79ac3fc0711127ad10e5ea435d |
| publicationDate | 2018-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180024593-A |
| titleOfInvention | Biomarker for predicting a risk of developing lung diseases and use thereof |
| abstract | The present invention relates to a marker composition for predicting the risk of pulmonary disease including a FGF2 (Fibroblast Growth Factor 2) gene or a protein encoded by the gene, a composition for predicting lung disease risk including an agent for measuring the gene or protein level, And an information providing method for predicting the risk of lung disease. The risk prediction method of lung disease according to the present invention is a proactive method for predicting the risk of developing lung disease by determining the level of FGF2 by measuring the level of pulmonary function so that early diagnosis and prediction of lung disease risk group It is expected that it will be useful for lowering the incidence of lung disease and enhancing the therapeutic effect because it can delay the onset of disease or prevent the onset through proper management and diagnose pulmonary disease early. |
| priorityDate | 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 203.